The company primarily operates a textile embroidery business using computerized machinery and has recently expanded into managing sports academies.
The company operates in a highly fragmented and commoditized textile segment with no evidence of pricing power, as reflected by deeply negative average net margins and low ROCE. There is no proprietary technology or brand strength that prevents customers from switching to competitors.
Capital allocation is poor, characterized by reinvestment into low-return assets and a lack of dividends despite maintaining a small cash balance. The company also engages in significant related-party transactions, including interest-free loans to group entities while carrying its own debt.
The company's demise was driven by a total collapse of internal controls and the crystallization of land valuation risks. By funneling capital into interest-free loans for related parties while neglecting its own core textile operations, the firm starved itself of necessary modernization. The qualified audit opinions eventually turned into a full-blown restatement or asset write-down as the disputed land parcels were reclaimed for public works, leaving the company with a hollowed-out balance sheet and no earnings power to service its remaining debt.
RichFakir rates United Leasing & Industries Ltd's business quality as poor — 18/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as none.
On our model, United Leasing & Industries Ltd is trading far above our estimate of fair value (expensive on our lens); we rate its price expensive. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on United Leasing & Industries Ltd is: Avoid. We are steering clear of this one — the red flags below outweigh anything the price or numbers offer.
RichFakir's educational estimate of United Leasing & Industries Ltd's fair value is about ₹12 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →